Safe Orthopaedics Announces the Publication of a Scientific Study Confirming the Financial Savings Generated by Its Single-us...
11 Septembre 2019 - 6:43PM
Business Wire
- The study conducted by a team from the Kremlin-Bicêtre
University Hospital involving 40 patients over one year compared
reusable and single-use instruments in lumbar spinal surgery
- Single-use instruments saved the hospital almost 2.5 hours per
operation, which represents an estimated financial saving of 181
euros
Regulatory News:
SAFE ORTHOPAEDICS (Paris:SAFOR) (FR0012452746 – SAFOR), a
company specialising in the design and marketing of implants and
single-use instruments for spinal surgery, announces the
publication in the European Journal of Orthopaedic Surgery &
Traumatology of an article written by a team from the
Kremlin-Bicêtre University Hospital presenting a one-year
randomised study on 40 patients who underwent spinal surgery. The
objective was to compare the cost of reusable and single-use
instruments.
Kremlin Bicêtre teams analysed all the steps necessary for a
spinal operation, from the preparation of the equipment beforehand
to the cleaning and sterilization of the reusable equipment and the
disposal of single-use instruments afterwards. They estimated the
cost of each step by taking into account the work time required in
both cases and the cost of the equipment used.
Financial advantage of single-use instruments resulting from
pre- and post-operative duration
The study shows that the average length of the operations was
the same for both groups. On the other hand, the time required for
preparation beforehand (ordering, restocking) and post-operation
procedures (cleaning, reconditioning, and sterilisation of
instruments) was almost 3 hours (exactly 176 minutes) in the case
of reusable instruments and only half an hour (precisely 33
minutes) with single-use instruments.
With reusable instruments, the post-operation disinfection phase
took 27.5 minutes, the assembly of instruments took 73.7 minutes,
and sterilization took 52.4 minutes, accounting for 87% of the
three hours required. With single-use instruments, the longest step
was the preparation of the kits, which took an average of 17
minutes. In total, the reduction in the overall process time with
single-use instruments was 143 minutes, representing a savings of
181 euros per operation for the hospital. This is in addition to
the potential increases in productivity that hospitals could
achieve by reallocating staff dedicated to equipment sterilization
operations.
Knowing that social security sets the purchase price of the
equipment for the manufacturers for each operation, the use of
single-use devices represented a saving of 26% for the
hospital.
Advantages of weight and availability of instruments
The study also identified two other interesting findings. The
first is the influence of work conditions on hospital staff. The
weight of the reusable instruments, which are transported to the
operating room in three boxes, totals 42 kg. They are therefore
difficult for staff to handle and can lead to musculoskeletal
problems over time. The weight of single-use instruments is limited
to 1.2 kg, because the instruments are more versatile and
non-metallic.
The second point highlighted by the Kremlin-Bicêtre study
concerns the availability of instruments. Given the time required
to sterilize and prepare the equipment, hospitals may have to delay
procedures due to the lack of availability of reusable instruments.
Single-use instruments are, by definition, always ready to use
because they are delivered sterile, with traceability for each
device.
“Our study shows that single-use instruments have a place in
spinal surgery, not only because of the cost savings they provide
for hospitals, but also because of their ease of use for surgeons
and the comfort they provide for hospital staff. Once this
innovative technology has been apprehended, the instruments are
reliable and versatile. Without modifying surgical technique, they
make it possible to optimize the operating durations as measured in
the study,” explained Professor Charles Court, surgeon at the
Kremlin-Bicêtre University Hospital.
“We thank and congratulate the Kremlin Bicêtre University
Hospital team for publishing its study on our technologies in the
European Journal of Orthopaedic Surgery & Traumatology, the
leading scientific journal in our sector. This randomized study
shows an 80% reduction in pre- and post-operative duration using
our technologies and offers the benefit to surgeons of having a
sterile, ready-to-use technology. Helping the surgeon reduce
surgical risks for the patient and enabling hospitals to reduce
their costs are important issues for Safe Orthopaedics,” declared
Pierre Dumouchel, CEO of Safe Orthopaedics.
About Safe Orthopaedics
Founded in 2010, Safe Orthopaedics, is a French medical
technology company that offers the safest technologies to treat
spinal fractures. Delivered sterile, all implants and respective
disposable instrumentation are available to the surgeon at any
time, anywhere. These technologies enable minimally invasive
approaches, redcucing risks of cross contamination and infection in
the interest of the patient. Protected by 17 patent families,
SteriSpineTM kits are CE marked and FDA cleared. The company is
based in Eragny-sur-Oise (95) and has 40 employees.
For more information: www.SafeOrthopaedics.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190911005658/en/
Safe Orthopaedics François-Henri Reynaud Chief Financial
and Administrative Officer Phone: +33 (0)1 34 21 50 00
investors@safeorthopaedics.com Investor Relations
NewCap Mathilde Bohin Phone: +33 (0)1 44 71 94 94 /
SafeOrtho@newcap.eu Media Relations Ulysse
Communication Bruno Arabian / 06 87 88 47 26 /
barabian@ulysse-communication.com Nicolas Daniels / 06 63 66 59 22
/ ndaniels@ulysse-communication.com